Literature DB >> 19066426

Expression of the osmotically responsive cationic channel TRPV4 in the endolymphatic sac.

H Kumagami1, M Terakado, Y Sainoo, A Baba, D Fujiyama, T Fukuda, K Takasaki, H Takahashi.   

Abstract

The immunohistochemical expression pattern and the physiological role of transient receptor potential vanilloid (TRPV) 4 in the endolymphatic sac were investigated. TRPV4 was expressed predominantly in the apical membrane of mitochondria-rich cells, and cell volume regulation by TRPV4 was observed in a tissue culture of the rat endolymphatic sac. TRPV4 was also present in the endolymphatic sacs of patients with vestibular schwannoma and with Ménière's disease. TRPV4 is assumed to play a role as an osmoreceptor in cell and fluid volume regulation in the human endolymphatic sac. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066426     DOI: 10.1159/000180290

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  5 in total

Review 1.  Ion homeostasis in the ear: mechanisms, maladies, and management.

Authors:  Dennis R Trune
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-10       Impact factor: 2.064

2.  Distribution and Assembly of TRP Ion Channels.

Authors:  Wei Cheng; Jie Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Mechanisms of otoconia and otolith development.

Authors:  Yunxia Wang Lundberg; Yinfang Xu; Kevin D Thiessen; Kenneth L Kramer
Journal:  Dev Dyn       Date:  2014-10-18       Impact factor: 3.780

Review 4.  Ion transport its regulation in the endolymphatic sac: suggestions for clinical aspects of Meniere's disease.

Authors:  Nozomu Mori; Takenori Miyashita; Ryuhei Inamoto; Ai Matsubara; Terushige Mori; Kosuke Akiyama; Hiroshi Hoshikawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-01       Impact factor: 2.503

5.  Selenium and Neurological Diseases: Focus on Peripheral Pain and TRP Channels.

Authors:  Mustafa Nazıroğlu; Ahmi Öz; Kenan Yıldızhan
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.